|
| A) | immunoglobulin. | ||
| B) | intact oral mucosa. | ||
| C) | the immune system. | ||
| D) | the immunomodulatory constituents in saliva. |
| A) | 6% | ||
| B) | 22% | ||
| C) | 50% | ||
| D) | 77% |
| A) | abscess. | ||
| B) | cellulitis. | ||
| C) | necrosis. | ||
| D) | inoculation. |
| A) | hypha. | ||
| B) | virion. | ||
| C) | capsid. | ||
| D) | beta-lactam ring. |
| A) | dental caries. | ||
| B) | traumatic injuries to teeth. | ||
| C) | gingival recession that exposes dentinal tubules. | ||
| D) | All of the above |
| A) | Prevotella intermedia | ||
| B) | Streptococcus viridans | ||
| C) | Porphyromonas gingivalis | ||
| D) | Fusobacterium nucleatum |
| A) | severe pain. | ||
| B) | pale and cool affected tissues. | ||
| C) | bleeding upon probing and suppuration. | ||
| D) | gingival tissue that is fluctuant in the initial stages. |
| A) | trauma. | ||
| B) | viral reactivation. | ||
| C) | poor dental hygiene. | ||
| D) | end-stage immunosuppressive disease. |
| A) | Halitosis | ||
| B) | Fistulous tracts | ||
| C) | Highly inflamed operculum | ||
| D) | Pain radiating toward the ear and the angle of the mandible |
| A) | The progressive immunosuppression of the host results in a lower degree of virulence. | ||
| B) | Aerobic bacteria are more likely to be found in periodontal infections in patients with compromised immune systems. | ||
| C) | There are no significant differences in pathogens responsible for periodontal disease in patients with immunocompromising conditions compared to healthy patients. | ||
| D) | Periodontal disease in patients with compromised immune systems is marked by a slower progression and limited involvement of gingival tissues and alveolar bone. |
| A) | responds to conventional periodontal treatment. | ||
| B) | improves with a meticulous at-home oral hygiene regimen. | ||
| C) | features a distinct erythematous band involving the marginal gingiva. | ||
| D) | is associated with significant signs and symptoms, including severe pain. |
| A) | viral origin. | ||
| B) | fungal origin. | ||
| C) | bacterial origin. | ||
| D) | unknown origin. |
| A) | NUP is characterized by deep periodontal pockets. | ||
| B) | Patients with NUP often experience severe pain and halitosis. | ||
| C) | In NUP, the gingival tissues necrose, followed by a rapid loss of the periodontal attachment. | ||
| D) | Compared with the progression of periodontal disease in immunocompetent patients, NUP features a more rapid onset. |
| A) | amoxicillin. | ||
| B) | clavulanate. | ||
| C) | clindamycin. | ||
| D) | metronidazole. |
| A) | 0.1% to 0.5% | ||
| B) | 5% to 7% | ||
| C) | 25% to 35% | ||
| D) | 50% to 70% |
| A) | hepatotoxicity and liver failure. | ||
| B) | respiratory depression and syncope. | ||
| C) | Clostridioides difficile-associated diarrhea and pseudomembranous colitis. | ||
| D) | potentiation of the anticoagulant effect of warfarin and severe headache. |
| A) | painful red lesions that cannot be removed. | ||
| B) | white lesions that cannot be removed by gentle scraping. | ||
| C) | red lesions localized to the radiating fissures at the corner of the mouth. | ||
| D) | white to yellow-white plaques that are easily removed from the involved area. |
| A) | Aspergillus spp. | ||
| B) | Coccidioides immitis | ||
| C) | Blastomyces dermatitidis | ||
| D) | All of the above |
| A) | one to two days. | ||
| B) | one to two weeks. | ||
| C) | one to two months. | ||
| D) | one year. |
| A) | warts. | ||
| B) | Kaposi sarcoma. | ||
| C) | postherpetic lesions. | ||
| D) | oral hairy leukoplakia. |